Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

ProMetic Life Sciences Inc T.PLI

Sector: Healthcare | Sub-Sector: Biotechnology

ProMetic Life Sciences Inc is a biopharmaceutical company. The Company is engaged in bioseparations, plasma-derived therapeutics and small-molecule drug development.
Price: $2.40 | Change: +$0.01 | %Change: +0.42%
Volume: 1.0m | Day High/Low: 2.43/2.33 | 52 Week High/Low: 2.87/0.97
View modes: 
3 stars

RE:$50 million financing

Sometime, there's simply no logical explanation. Welcome to the stock market!!!! I've said it before, but daytrading is a killer for that kind of stock. Either you trust the company in a long term...read more
1 star

RE:RE:$50 million financing

I do not see a problem but I do not see any deals or  news so we have cash that we all gave up $$$ to have the cash that part is easy to understand . IMHO sky  your posts are always regarded as great...read more
5 stars

RE:$50 million financing

We can assume 61M $ ( 50 + 7 over allotment + 4 Thomvest) means with remaining cash = +-  75 $M  on balance sheet. Trading at 20 cents discount .... The drop matches the IBB bio index quite...read more
0 stars

the drop

Hard to figure why the sp has dropped especially after Cannacord's involvement.   Just like you, I would like to know.   A friend was suggesting that anticipate a big run up and investors, not me, try...read more
3 stars

Well if we start the year at $2.00 what's a good finish?

100%    200%  300%   I guess we will have wait and see what Mr Market gives us . He's been good so far. IMHO sky  rate and reply
5 stars

$50 million financing

Knocked $225 million off the market value of PLI. Isn't there a better way?  rate and reply
3 stars

Off Topic " This could happen after PBI-4050 Sept "

The Tiny Biotech Getting Free Lunch from Big Pharma By Kristine Harjes | More Articles May 3, 2015 | Comments (0) Source: Portola Pharmaceuticals There's no such thing as free lunch, right...read more
1 star

RE:Easy 1.40/ share increase around the corner. Hostile takeout

I dont see any increase coming anytime soon, at least not with the information before us.  When youre still waiting for "busy April 2014" and you are a company with one deal announced - with an...read more
4 stars

Easy 1.40/ share increase around the corner. Hostile takeout

The people that know and studied this company in detail know that the above is within its. grasp very quickly.  The company of this measure, having so many positive options is not trade below four...read more
0 stars

Someone needs to roll out Ultimate Fact Checking... LOL

On the internet accross the globe. There is enough tech out there that it could be done easily. It would eliminate a lot clutter from people posting crud. Just as there are millions of ads to say who...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:PLI on BNN

Bepando how can they be aloud to comment and be so far off from the truth ? Sky  rate and reply
4 stars

RE:RE:RE:RE:RE:RE:RE:RE:PLI on BNN

Chances a very good Campbell was mistaken when referring to a company with a liver fibrosis drug being bought for over $8 B. Likely he was referring to Intermune's pirfenidone (Esbriet) which is for...read more
1 star

Off Topic nothing else to talk about

Biotech investors flock to follow-on offerings The Globe and Mail‎ - 1 day ago Drugmakers are raising money at levels not seen in at least a decade, with many of the same biotechnology firms that...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:PLI on BNN

anyone know the liver drug name or #  rate and reply
0 stars

And out of interest - Hap Sneddon?

I should like to address a number of points here that seem to me to be necessary about Hap (Robert) Sneddon FCSI , Portfolio Manager/Analyst. Compiling comments that experts make about stocks while...read more
2 stars

RE:via stock chase - Bruce C , Comments

Yes I have heard of these rumours fibrosis was his name he should be town by September as the Tale goes  rate and reply
4.5 stars

via stock chase - Bruce C , Comments

Did some trimming at $2.50. This is a story that could be $10. They have a drug that treats liver cirrhosis, which could be a complete home run. Also, have a plasma treatment plant in Québec. However,...read more
2.5 stars

RE:RE:RE:RE:RE:RE:PLI on BNN


...read more
1.5 stars

RE:RE:RE:RE:RE:PLI on BNN


...read more
0 stars

RE:RE:RE:RE:PLI on BNN

Your comments on Bruce Campbell (1) last take on PLI...at BNN show this afternoon  rate and reply